Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today ...

Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease ...

Critical Access Hospital IT, clinical, and financial users cite repackaged health-system solutions, misaligned implementation ...

Pro Forma Revenue Expected to exceed $20M (~4x 2024 Revenue)Wattbike Air-Pro Sells 700+ Units / ~$2.5M in UK Commercial ...

Ombudsman’s investigation triggers review of cancer treatment wait times at NHS Trust An investigation by England’s Health ...

ANKTIVA, in combination with an immune checkpoint inhibitor, has received accelerated approval from the Saudi Food and Drug ...

Linesight forecast a rebound following two years of contraction, fueled by strong data center pipeline amid ongoing labor and ...

The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its ...

Portal Innovations announced continued growth at Portal Atlanta at Science Square, with the addition of seven new member ...

Lowers the barrier to SPR by reducing sample requirements to microliter scale – up to 99% less material than traditional ...

Genomics leader relocates to an expanded footprint in SunnyvaleNew location enables customer continuity and provides ...